Chronic venous disease and the leukocyte-endothelium interaction: From symptoms to ulceration

Angiology

Volumn 56, Issue SUPPL. 1, 2005, Pages

  Nicolaides, A N ^a,b  

^a Cyprus Institute of Neurology and Genetics ^*

^b CYPRUS INSTITUTE OF NEUROLOGY AND GENETICS   (Cyprus)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GROWTH FACTOR; MATRIX METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE;

CELL INTERACTION; CHRONIC INFLAMMATION; CHRONIC VEIN INSUFFICIENCY; CLINICAL FEATURE; CONFERENCE PAPER; CYTOKINE RELEASE; DISEASE ASSOCIATION; ENDOTHELIUM; EXTRACELLULAR MATRIX; HUMAN; HYPERTENSION; INFLAMMATION; INTERSTITIUM; LEUKOCYTE; LEUKOCYTE MIGRATION; MACROPHAGE; MAST CELL; MITRAL VALVE REGURGITATION; MONOCYTE; MORBIDITY; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; RISK REDUCTION; SKIN BLOOD FLOW; SKIN FIBROSIS; SYMPTOMATOLOGY; VARICOSIS; VEIN BLOOD FLOW; VEIN VALVE; VEIN WALL; VENOUS PRESSURE; ARTICLE; DISEASE COURSE; DISEASE TRANSMISSION; EDEMA; ENDOTHELIUM CELL; LEUKOCYTE ENDOTHELIUM INTERACTION; LYMPHATIC DRAINAGE; MOLECULAR INTERACTION; PATHOGENESIS; PREVALENCE; ULCER; VEIN DISEASE;

EID: 25444502110     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/00033197050560i103     Document Type: Conference Paper

References (36)

1. Ramelet AA, Kern P, Perrin M, eds: Les varices et télangiectasies (in French). Paris: Masson, 2003, pp 7-16.
2. Porter JM, Moneta GL: International Consensus Committee on chronic venous disease. Reporting standards in venous disease: An update. J Vasc Surg 21:635-645, 1995.
3. Pannier-Fischer F, Rabe E: Epidemiology of chronic venous diseases. Hautarzt 54:1037-1044, 2003.
4. Jawien A, Grzela T, Ochwat A: Prevalence of chronic venous insufficiency in men and women in Poland: Multicentre cross-sectional study in 40,095 patients. Phlebology 18:110-122, 2003.
5. Labropoulos N: Hemodynamic changes according to the CEAP classification. Phlebolymphology 40:130-136, 2003.
6. Masuda EM, Kisner RL, Eklof B, et al: Practical application of the CEAP classification. In: Chronic Venous Insufficiency, Diagnosis and Treatment, ed. by Ballard JL, Bergan JJ. London: Springer-Verlag London Limited, 2000, pp 41-49.
7. Scuderi A, Raskin B, Assal FA, et al: The incidence of venous disease in Brazil based on the CEAP classification. An epidemiological study. Int Angiol 21:316-321, 2002.
8. Carpentier PH, Cornu-Thénard A, Uhl JF, et al, and the European working group on the clinical characterisation of venous disorders: Appraisal of the information content of the C classes of CEAP clinical classification of chronic venous disorders: A multicenter evaluation of 872 patients. J Vasc Surg 37:827-833, 2003.
9. Boisseau MR: Pharmacologie des médicaments veinotoniques: Données actuelles sur leur mode d'action et les cibles thérapeutiques (in French). Angéiologie 52:71-77, 2000.
10. Boisseau M, Freyburger G, Busquet M, et al: Hemorheological disturbances in venous insufficiency after induced stasis. Clin Hemorheol 9:161-163, 1989.
11. Le Devehat C, Boisseau MR, Vimeux M, et al: Hemorheological factors in the pathophysiology of venous disease. Clin Hemorheol 9:861-870, 1989.
12. Kahn SR, M'lan CE, Lamping DL, et al; VEINES Study Group: Relationship between clinical classification of chronic venous disease and patient-reported quality of life: Results from an international cohort study. J Vasc Surg 39:823-828, 2004.
13. Labropoulos N: Inflammation parallels severity of chronic venous insufficiency. Phlebology 18:78-82, 2003.
14. Bradbury A, Evans C, Allan P, et al: What are the symptoms of varicose veins? Edinburgh vein study cross sectional population survey. BMJ 318:353-356, 1999.
15. Bradbury A, Evans CJ, Allan P, et al: The relationship between lower limb symptoms and superficial and deep venous reflux on duplex ultrasonography: The Edinburgh Vein Study. J Vasc Surg 32:921-931, 2000.
16. Howlader MH, Coleridge Smith PD: Symptoms of chronic venous disease and association with systemic inflammatory markers. J Vasc Surg 38:950-954, 2003.
17. Agence Nationale d'Accréditation et d'Evaluation de la Santé (in French). Evaluation et suivi de la douleur chronique chez l'adulte en médecine ambulatoire (in French). Available at: www.anaes.fr
18. Perrin M, Arnould B, Regnault A, et al: Relationship between symptoms, signs, reflux and quality of life in patients with chronic venous disease: A multicenter study. Oral presentation at the 16th Annual Meeting of the American Venous Forum (AVF), Orlando, USA, February 26-29, 2004.
19. Ramelet AA: Clinical benefits of Daflon 500 mg in the most severe stages of chronic venous insufficiency. Angiology 52(suppl):S49-S56, 2001.
20. Garde C, Nicolaides A, Guex JJ, et al: First consensus meeting on venoactive drugs. Effects of venoactive agents on edema in chronic venous disease. Phlébologie - Annales Vasculaires 57:7-13, 2004.
21. Levick JR, McHale N: The physiology of lymph production and propulsion. In: Diseases of the Lymphatics, ed. by Browse N, Burnand KG, Mortimer PS. London: Arnold, 2003, pp 44-64.
22. McCloskey KD, Toland HM, Hollywood MA, et al: Hyperpolarisation-activated inward current in isolated sheep mesenteric lymphatic smooth muscle. J Physiol 521:201-211, 1999.
23. Hagendoorn J, Padera TP, Kashiwagi S, et al: Endothelial nitric oxide synthase regulates microlymphatic flow via collecting lymphatics. Circ Res 95:204-209, 2004.
24. International Task Force: The management of chronic venous disorders of the leg: An evidence-based report of an international task force. Phlebology 14(suppl 1):23-34, 1999.
25. Schultz-Ehrenburg U, Reich S, Robak-Pawelczyk B, et al: Prospective epidemiological study of developing varicose veins over a period of two decades (Bochum I-IV). Abstract presented at the 2003 UIP World Chapter Meeting. August 27-31, 2003, in San Diego, CA, USA.
26. Aravind B, Davies AH: Editorial. Phlebology 19:55-56, 2004.
27. Ono T, Bergan JJ, Schmid-Schönbein GW, et al: Monocyte infiltration into venous valves. J Vasc Surg 27:158-166, 1998.
28. Coleridge Smith PD, Bergan JJ: Inflammation in venous disease. In: Molecular Basis for Microcirculatory Disorders, ed. by Schmid-Schönbein GW, Granger N. Paris: Springer-Verlag, 2003, pp 489-500.
29. Yamada T, Tomita S, Mori M, et al: Increased mast cell infiltration in varicose veins of the lower limbs: A possible role in the development of varices. Surgery 119:494-497, 1996.
30. Jacob MP, Badier-Commander C, Fontaine V, et al: Extracellular matrix remodeling in the vascular wall. Pathol Biol 49:326-332, 2001.
31. Badier-Commander C, Verbeuren T, Lebard C, et al: Increased TIMP/MMP ratio in varicose veins: A possible explanation for extracellular matrix accumulation. J Pathol 192:105-112, 2000.
32. Badier-Commander C, Couvelard A, Henin D, et al: Smooth muscle cell modulation and cytokine overproduction in varicose veins. An in situ study. J Pathol 193:398-407, 2001.
33. Thomas PR, Nash GB, Dormandy JA: White cell accumulation in dependent legs of patients with venous hypertension: A possible mechanism for trophic changes in the skin. BMJ 296:1693-1695, 1988.
34. Vanscheidt WQ, Kresse O, Hach-Wunderle V, et al: Leg ulcer patients: No decreased fibrinolytic response but white cell trapping after venous occlusion of the upper limb. Phlebology 7:92-96, 1992.
35. Takase S, Schmid-Schönbein G, Bergan JJ: Leukocyte activation in patients with venous insufficiency. J Vasc Surg 30:148-156, 1999.
36. 1 gene expression and protein production. J Vasc Surg 30:1129-1145, 1999.